Abstract: The present invention provides L-arginine salts of 4- or 5-aminosalicylic acid, and a pharmaceutical composition containing these L-arginine salts of 4- or 5-aminosalicylic acid as active ingredients, useful for the treatment of an inflammatory condition of the GI tract such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).
Type:
Application
Filed:
May 27, 2005
Publication date:
January 5, 2006
Applicant:
ANTIBE THERAPEUTICS INC.
Inventors:
JOHN WALLACE, GIUSEPPE CIRINO, ANNA SPARATORE
© 2024 Justia
